Hologic, Inc.

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP
436440101
SEDOL
BYZH6J4
CIK
0000859737
www.hologic.com
LEI:
©
FIGI: BBG000C3NTN5
HOLX
Hologic, Inc.
GICS: 35101010 · Sector: Healthcare · Sub-Sector: Medical Instruments & Supplies
AI
PROFILER
NAME
Hologic, Inc.
ISIN
US4364401012
TICKER
HOLX
MIC
XNAS
REUTERS
HOLX.OQ
BLOOMBERG
HOLX US
BUILD THEMEFOLIO SHARE IDEAS DISCUSS
LEVERAGE INVEST
EN 728x90
Financial Intelligence
360° iHub Crowd iFeed ATH Tracker Index Tracker ETF TF Spicy2 X-Billboard
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
TradingView ActivTrader MT4 MT5
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Wed, 18.12.2024       Hologic
US4364401012

Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into an agreement with the Centers for Disease Control and Prevention (CDC) to develop analyte specific reagents (ASRs) — the “active ingredients” of laboratory-developed tests used to identify specific diseases or conditions — that would aid in the detection of H5N1 bird flu. This ...
Read More
Hologic
Technical Analysis Termsheet Terminal
Permalink
Tue, 10.12.2024       Hologic
US4364401012

Hologic, Inc., (Nasdaq: HOLX) a global leader in women’s health focused on developing innovative medical technologies that effectively detect, diagnose and treat health conditions, today issued the following statement regarding the United States Preventive Services Task Force draft guidelines for cervical cancer screening: “Today’s recommendatio...
Read More
Hologic
Technical Analysis Termsheet Terminal
Permalink
Mon, 09.12.2024       Hologic
US4364401012

Hologic, Inc. (Nasdaq: HOLX) announced today that Martin Madaus has been elected to the Company’s Board of Directors, effective December 6, 2024. Dr. Madaus was also appointed to the Compensation Committee and the Nominating and Corporate Governance Committee effective December 6, 2024. This press release features multimedia. View the full releas...
Read More
Hologic
Technical Analysis Termsheet Terminal
Permalink
Mon, 09.12.2024       Hologic
US4364401012

Four new studies regarding the Breast Cancer Index (BCI) test will be presented at the 2024 San Antonio Breast Cancer Symposium (SABCS). Among these studies, initial data will be premiered investigating the potential role of the BCI test to identify postmenopausal women with hormone-receptor positive (HR+), early-stage, node-negative disease who a...
Read More
Hologic
Technical Analysis Termsheet Terminal
Permalink
Mon, 02.12.2024       Hologic
US4364401012

Hologic, Inc. (Nasdaq: HOLX) yesterday presented new research demonstrating the performance of its Genius AI® Detection 2.0 software across diverse patient populations at the 110th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA). This press release features multimedia. View the full release here: https:/...
Read More
Hologic
Technical Analysis Termsheet Terminal
Permalink
Mon, 25.11.2024       Hologic
US4364401012

Hologic, Inc. (Nasdaq: HOLX) will reveal new technologies reimagining the future of breast health at the 110th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago on December 1-5. On the show floor and during multiple workshops, Hologic will showcase AI-powered breast imaging advancements designed ...
Read More
Hologic
Technical Analysis Termsheet Terminal
Permalink
Thu, 14.11.2024       Hologic
US4364401012

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the following upcoming investor conferences: 2024 Stephens Annual Investment Conference in Nashville, TN on Thursday, November 21st, at 10 a.m. Central Time (CT). 7th Annual Evercore ISI HealthCONx Conference in Coral Gables, FL on Tuesday, December 3rd, at 2:10 p....
Read More
Hologic
Technical Analysis Termsheet Terminal
Permalink
Mon, 04.11.2024       Hologic
US4364401012

Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal fourth quarter ended September 28, 2024. "We delivered strong fiscal 2024 results, reinforcing our track record of durable performance with another solid quarter of growth," said Steve MacMillan, Hologic’s chairman, president, and chief executive officer. ...
Read More
Hologic
Technical Analysis Termsheet Terminal
Permalink
Mon, 14.10.2024       Hologic
US4364401012

Hologic, Inc. (Nasdaq: HOLX), a global champion of women’s health, today announced that it has signed a definitive agreement to acquire Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the development of minimally invasive solutions for women’s health for approximately $350 million, subject to working capital and ...
Read More
Hologic
Technical Analysis Termsheet Terminal
Permalink
Fri, 04.10.2024       Hologic
US4364401012

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2024 on Monday, November 4, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants may listen to the call by dia...
Read More
Hologic
Technical Analysis Termsheet Terminal
Permalink
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S